R&D organization of a global pharmaceutical company

Increased efficiency in clinical development

• Communication
• Change Management

• Clinical excellence
• State-of-the-art processes and methods
• Communication strategy and roll-out plan

R&D organization of a global pharmaceutical company

Utilization of patient experiences and expectations from social media

• Planning and implementation of a global research challenge (technology assessment)
• Coordination of pilot projects

• State of the technology
• Minimum viable product of a software application
• Roadmap for further development of the application

R&D organization of a global pharmaceutical company

Development of endpoints for a phase 3 clinical trial

• Coordination of a cross-functional R&D team to clarify medical needs, measurementinstrument and endpoint structure

• Submission of an endpoint concept to regulatory authorities (FDA; EMA)

Multinational chemistry company

Realignment and strategy Research and development of electronic materials

• Portfolio analysis
• IP Analysis
• Technology trend analysis
• Market analysis

Strategy, project portfolio and processes realigned; implementation. Technological/IP buy and build strategy

International life science company

Development of an innovation portfolio in the field of phototherapy

Interdisciplinary teams of doctors, engineers, IP and marketing  

Prototypes for clinical tests developed, provided, evaluated

Dax 40 company

Development of sustainability-based innovation processes/ technology unit

• Requirement analysis
• Business model analysis
• Stage-gate process
• KPI selection
• Team building
• Budget requirement analysis

Company-wide role-out of a sustainability-based innovation process

International company Cosmetics Actives Raw materials

Strategic expansion of product portfolio, adaptation of development strategies

• IP, market and product portfolio analysis
• Technology portfolio analysis
• R&D investment analysis and benchmark  

Implementation of new development approach, launch of a natural substance-analog cosmetic active ingredient product portfolio 

International company in the semiconductor industry

Innovation portfolio analysis and innovation strategy

• IP, market and product portfolio analysis
• Technology portfolio analysis
• R&D investment analysis and benchmark

Innovation strategy, evaluation criteria and stage-gate process; Implemented. Short to long-term innovation pipeline established

International life science company

Development of a Bioactives innovation strategy

• Business model and technology analysis
• Profitability analysis
• M&A target identification in the field of active ingredients

Implementation of a new Bioactives business unit